Tumgik
Visit Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Fun Fact
The KCSC sent more than 20K requests to delete posts related to prostitution and porn to Tumblr from January to June 2017.
#Matinas BioPharma Hldgs
stockcalc · 3 years
Text
Cardiff Oncology (CRDF:NAS) Fundamental Valuation Report
Cardiff Oncology (CRDF:NAS) Fundamental Valuation Report
Fundamental Valuation Report Cardiff Oncology(CRDF:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$8.80 (USD) 04/22/2021 Weighted Valuation$9.27 (USD) Overall RatingUndervalued by 5.3% Valuation Models Comparables: $10.32 (USD) Adjusted Book Value: $8.57 (USD) Valuation…
View On WordPress
#adjusted book value#AMPE#Ampio Pharmaceuticals#Cardiff Oncology#Cogent Biosciences#COGT#comps#CRDF#DCF#discounted cash flow#fundamental analysis#IBIO#intrinsic value#Matinas BioPharma Hldgs#MTNB#Pfenex#PFNX#undervalued#valuation
1 note · View note
newmarketresearch1 · 5 years
Text
Nanoencapsulation for Food Products Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Nanoencapsulation is a technology, which involves packaging of nanoparticles of gas, liquids or solids within a secondary material. The nanoparticles are known as core or active, and the secondary material is known as shell or matrix. The core includes active ingredients such as drugs, biocides, perfumes and vitamins whereas, shell provides isolation and protection to the core until its being released.
Request For Sample Copy of this Research Report : https://www.coherentmarketinsights.com/insight/request-sample/1623
Nanoencapsulation in food industry, is used to deliver essential bioactive compounds to intended areas of the body. Various processes such as nanoemulsification, nanoestructuration, and nanocomposites are used to incorporate, absorb and disperse bioactive compounds such as antioxidants, proteins, lipids, and carbohydrates within nano-sized vesicles. The application of nanoencapsulation technology in the food industry enables delivery of difficult-to-attain nutrients to the body by incorporating them in functional and fortified food products. Furthermore, nanocapsulation in the form of nanomicellees (protein-based Carrier System) and liposomes are most widely used in food supplements and functional beverages.
Market Dynamics
Steadily growing demand for functional food products with enhanced bioavailability of nutrients is majorly driving growth of the global nanoencapsulation market. Furthermore, growing demand for nutraceuticals and the availability of a wide variety of nanocarrier based nutraceutical food products, containing nano-antimicrobials and nano-antioxidants is supporting growth of the market. For instance, according to Coherent Market Insights’ analysis, the global nutraceutical ingredients market was valued at US$ 30.57 billion in 2016, and is expected to exhibit a CAGR of 7.31% over the forecast period of 2018–2025 to reach US$ 57.46 billion by 2025.
Moreover, the nanoencapsulation technology enhances the stability and shelf life of the food products, which is considered as another factor driving the growth of the global nanoencapsulation for food products market.
However, manufacturing process of nutrient nanoparticles involves usage of high-energy consuming machines, in order to break food materials into nano-sized particles. Thus, high cost of machines and high energy demand makes the nutrient nanoparticles manufacturing process expensive. Thereby, high production cost of the nutrient nanoparticles, is a major challenge to growth of the global nanoencapsulation for food products market.
Market Outlook
In North America, the U.S. was the dominated country in the nanoencapsulation for food products market. This is majorly attributed to growing food and beverages industry in the country. According to the data provided by United States Department of Agriculture (USDA), in 2016, over 35,000 food and beverages manufacturing plants located throughout the country. Furthermore, high consumption of meat and bakery products is also propelling growth of the nanoencapsulation market in the region, as edible coatings of nanoparticles are used on vegetables, fruits, meats, and bakery products. According to the USDA, the total production of red meat in January to March 2018 was 13,166.9 million tons in the U.S. Thus, growing demand for meat products is anticipated to support growth of the nanoencapsulation for the food products market. Moreover, growing demand for food and beverages, with high vitamin content is boosting the market growth in North America, as nanoencapsulation technology is used to incorporate and absorb the vitamins within nano-sized vesicles. For instance, according to the Coherent Market Insights’ analysis, North America was dominant in the global vitamins market in 2016 and recoded high demand from the food and beverages sector.
Asia Pacific is anticipated to record the fastest growth in the global nanoencapsulation market, during the forecast period. Owing to rising awareness towards maintaing a healthy life style, functional food and beverages are largely gaining popularity, in the region. This in turn is expected to aid in growth of the global nanoencapsulation for food products market. Furthermore, growing food processing industry in the region, is anticipated to be another driver for the market growth. For instance, according to the United States Department of Agriculture (USDA), food processing industry in Japan was valued at US$ 216.1 billion in 2016. Therefore, these factors are expected to aid in growth of the market in the region of Asia Pacific over the forecast period.
Key Players
Major players operating in the global nanoencapsulation for food products market include Aquanova AG, Frutarom Industries Ltd., Thies Technology Inc., Blue California, Southwest Research Institute, ANP Technologies Inc., Carlina Technologies, ANP Technologies, Encapsula NanoSciences LLC, Powderment Inc., and Matinas Biopharma Hldgs.
For More Information: https://www.coherentmarketinsights.com/ongoing-insight/nanoencapsulation-for-food-products-market-1623
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
0 notes
stockcalc · 3 years
Text
Albireo Pharma (ALBO:NAS) Fundamental Valuation Report
Albireo Pharma (ALBO:NAS) Fundamental Valuation Report
Fundamental Valuation Report Albireo Pharma(ALBO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$32.92 (USD) 04/15/2021 Weighted Valuation$31.89 (USD) Overall RatingFairly valued to slightly Overvalued by 3.1% Valuation Models Adjusted Book Value: $27.17…
Tumblr media
View On WordPress
#adjusted book value#Albireo Pharma#ALBO#Clovis Oncology#CLVS#comps#DCF#discounted cash flow#Evelo Biosciences#EVLO#fairlyvalued#fundamental analysis#IBIO#intrinsic value#Matinas BioPharma Hldgs#MTNB#Pfenex#PFNX#valuation
1 note · View note
stockcalc · 3 years
Text
Vaxart (VXRT:NAS) Fundamental Valuation Report
Vaxart (VXRT:NAS) Fundamental Valuation Report
Fundamental Valuation Report Vaxart(VXRT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$6.70 (USD) 05/21/2021 Weighted Valuation$6.34 (USD) Overall RatingOvervalued by 5.4% Valuation Models Comparables: $6.34 (USD) Valuation Methods This company is: Cash Flow: Overvalued…
View On WordPress
#adjusted book value#AMPE#Ampio Pharmaceuticals#BioXcel Therapeutics#BTAI#comps#DCF#discounted cash flow#fundamental analysis#IBIO#intrinsic value#Matinas BioPharma Hldgs#MTNB#overvalued#Pfenex#PFNX#valuation#Vaxart#VXRT
0 notes
stockcalc · 3 years
Text
Voyager Therapeutics (VYGR:NAS) Fundamental Valuation Report
Voyager Therapeutics (VYGR:NAS) Fundamental Valuation Report
Fundamental Valuation Report Voyager Therapeutics(VYGR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.26 (USD) 05/21/2021 Weighted Valuation$6.09 (USD) Overall RatingUndervalued by 43.0% Valuation Models Discounted Cash Flow: $6.10 (USD) Comparables: $6.09…
Tumblr media
View On WordPress
#Actinium Pharmaceuticals#adjusted book value#AMPE#Ampio Pharmaceuticals#ATNM#comps#DCF#discounted cash flow#fundamental analysis#IBIO#intrinsic value#Matinas BioPharma Hldgs#MTNB#Pfenex#PFNX#undervalued#valuation#Voyager Therapeutics#VYGR
0 notes
stockcalc · 3 years
Text
Vaxart (VXRT:NAS) Fundamental Valuation Report
Vaxart (VXRT:NAS) Fundamental Valuation Report
Fundamental Valuation Report Vaxart(VXRT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$6.70 (USD) 05/21/2021 Weighted Valuation$6.34 (USD) Overall RatingOvervalued by 5.4% Valuation Models Comparables: $6.34 (USD) Valuation Methods This company is: Cash Flow: Overvalued…
Tumblr media
View On WordPress
#adjusted book value#AMPE#Ampio Pharmaceuticals#BioXcel Therapeutics#BTAI#comps#DCF#discounted cash flow#fundamental analysis#IBIO#intrinsic value#Matinas BioPharma Hldgs#MTNB#overvalued#Pfenex#PFNX#valuation#Vaxart#VXRT
0 notes
stockcalc · 3 years
Text
Voyager Therapeutics (VYGR:NAS) Fundamental Valuation Report
Voyager Therapeutics (VYGR:NAS) Fundamental Valuation Report
Fundamental Valuation Report Voyager Therapeutics(VYGR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.26 (USD) 05/21/2021 Weighted Valuation$6.09 (USD) Overall RatingUndervalued by 43.0% Valuation Models Discounted Cash Flow: $6.10 (USD) Comparables: $6.09…
Tumblr media
View On WordPress
#Actinium Pharmaceuticals#adjusted book value#AMPE#Ampio Pharmaceuticals#ATNM#comps#DCF#discounted cash flow#fundamental analysis#IBIO#intrinsic value#Matinas BioPharma Hldgs#MTNB#Pfenex#PFNX#undervalued#valuation#Voyager Therapeutics#VYGR
0 notes
stockcalc · 3 years
Text
Provention Bio (PRVB:NAS) Fundamental Valuation Report
Provention Bio (PRVB:NAS) Fundamental Valuation Report
Fundamental Valuation Report Provention Bio(PRVB:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$6.80 (USD) 05/12/2021 Weighted Valuation$12.62 (USD) Overall RatingUndervalued by 85.5% Valuation Models Comparables: $12.94 (USD) Adjusted Book Value: $12.13 (USD) Valuation…
View On WordPress
#adjusted book value#AMPE#Ampio Pharmaceuticals#comps#CUE#Cue Biopharma#DCF#discounted cash flow#fundamental analysis#IBIO#intrinsic value#Matinas BioPharma Hldgs#MTNB#Pfenex#PFNX#Provention Bio#PRVB#undervalued#valuation
0 notes
stockcalc · 3 years
Text
Provention Bio (PRVB:NAS) Fundamental Valuation Report
Provention Bio (PRVB:NAS) Fundamental Valuation Report
Fundamental Valuation Report Provention Bio(PRVB:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$6.80 (USD) 05/12/2021 Weighted Valuation$12.62 (USD) Overall RatingUndervalued by 85.5% Valuation Models Comparables: $12.94 (USD) Adjusted Book Value: $12.13 (USD) Valuation…
Tumblr media
View On WordPress
#adjusted book value#AMPE#Ampio Pharmaceuticals#comps#CUE#Cue Biopharma#DCF#discounted cash flow#fundamental analysis#IBIO#intrinsic value#Matinas BioPharma Hldgs#MTNB#Pfenex#PFNX#Provention Bio#PRVB#undervalued#valuation
0 notes
stockcalc · 3 years
Text
Kala Pharmaceuticals (KALA:NAS) Fundamental Valuation Report
Kala Pharmaceuticals (KALA:NAS) Fundamental Valuation Report
Fundamental Valuation Report Kala Pharmaceuticals(KALA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$6.45 (USD) 05/04/2021 Weighted Valuation$6.67 (USD) Overall RatingFairly valued to slightly Undervalued by 3.4% Valuation Models Adjusted Book Value: $6.53…
Tumblr media
View On WordPress
#Actinium Pharmaceuticals#adjusted book value#AMPE#Ampio Pharmaceuticals#ATNM#comps#DCF#discounted cash flow#fairlyvalued#fundamental analysis#IBIO#intrinsic value#KALA#Kala Pharmaceuticals#Matinas BioPharma Hldgs#MTNB#Pfenex#PFNX#valuation
0 notes
stockcalc · 3 years
Text
Kala Pharmaceuticals (KALA:NAS) Fundamental Valuation Report
Kala Pharmaceuticals (KALA:NAS) Fundamental Valuation Report
Fundamental Valuation Report Kala Pharmaceuticals(KALA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$6.45 (USD) 05/04/2021 Weighted Valuation$6.67 (USD) Overall RatingFairly valued to slightly Undervalued by 3.4% Valuation Models Adjusted Book Value: $6.53…
Tumblr media
View On WordPress
#Actinium Pharmaceuticals#adjusted book value#AMPE#Ampio Pharmaceuticals#ATNM#comps#DCF#discounted cash flow#fairlyvalued#fundamental analysis#IBIO#intrinsic value#KALA#Kala Pharmaceuticals#Matinas BioPharma Hldgs#MTNB#Pfenex#PFNX#valuation
0 notes
stockcalc · 3 years
Text
Jounce Therapeutics (JNCE:NAS) Fundamental Valuation Report
Jounce Therapeutics (JNCE:NAS) Fundamental Valuation Report
Fundamental Valuation Report Jounce Therapeutics(JNCE:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$9.43 (USD) 04/30/2021 Weighted Valuation$10.14 (USD) Overall RatingUndervalued by 7.5% Valuation Models Adjusted Book Value: $10.14 (USD) Valuation Methods This company…
Tumblr media
View On WordPress
#adjusted book value#AMPE#Ampio Pharmaceuticals#comps#DCF#discounted cash flow#fundamental analysis#IBIO#intrinsic value#JNCE#Jounce Therapeutics#Matinas BioPharma Hldgs#MTNB#Pfenex#PFNX#undervalued#valuation#VistaGen Therapeutics#VTGN
0 notes
stockcalc · 3 years
Text
Jounce Therapeutics (JNCE:NAS) Fundamental Valuation Report
Jounce Therapeutics (JNCE:NAS) Fundamental Valuation Report
Fundamental Valuation Report Jounce Therapeutics(JNCE:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$9.43 (USD) 04/30/2021 Weighted Valuation$10.14 (USD) Overall RatingUndervalued by 7.5% Valuation Models Adjusted Book Value: $10.14 (USD) Valuation Methods This company…
Tumblr media
View On WordPress
#adjusted book value#AMPE#Ampio Pharmaceuticals#comps#DCF#discounted cash flow#fundamental analysis#IBIO#intrinsic value#JNCE#Jounce Therapeutics#Matinas BioPharma Hldgs#MTNB#Pfenex#PFNX#undervalued#valuation#VistaGen Therapeutics#VTGN
0 notes
stockcalc · 3 years
Text
Intercept Pharmaceuticals (ICPT:NAS) Fundamental Valuation Report
Intercept Pharmaceuticals (ICPT:NAS) Fundamental Valuation Report
Fundamental Valuation Report Intercept Pharmaceuticals(ICPT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$19.78 (USD) 04/30/2021 Weighted Valuation$10.32 (USD) Overall RatingOvervalued by 47.8% Valuation Models Comparables: $10.32 (USD) Valuation Methods This company…
View On WordPress
#adjusted book value#ANAB#AnaptysBio#CARA#Cara Therapeutics#comps#DCF#discounted cash flow#fundamental analysis#ICPT#Intercept Pharmaceuticals#intrinsic value#Matinas BioPharma Hldgs#MTNB#overvalued#Pfenex#PFNX#Relmada Therapeutics#RLMD#valuation
0 notes
stockcalc · 3 years
Text
Intercept Pharmaceuticals (ICPT:NAS) Fundamental Valuation Report
Intercept Pharmaceuticals (ICPT:NAS) Fundamental Valuation Report
Fundamental Valuation Report Intercept Pharmaceuticals(ICPT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$19.78 (USD) 04/30/2021 Weighted Valuation$10.32 (USD) Overall RatingOvervalued by 47.8% Valuation Models Comparables: $10.32 (USD) Valuation Methods This company…
Tumblr media
View On WordPress
#adjusted book value#ANAB#AnaptysBio#CARA#Cara Therapeutics#comps#DCF#discounted cash flow#fundamental analysis#ICPT#Intercept Pharmaceuticals#intrinsic value#Matinas BioPharma Hldgs#MTNB#overvalued#Pfenex#PFNX#Relmada Therapeutics#RLMD#valuation
0 notes
stockcalc · 3 years
Text
Cyclerion Therapeutics (CYCN:NAS) Fundamental Valuation Report
Cyclerion Therapeutics (CYCN:NAS) Fundamental Valuation Report
Fundamental Valuation Report Cyclerion Therapeutics(CYCN:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$2.78 (USD) 04/22/2021 Weighted Valuation$2.55 (USD) Overall RatingOvervalued by 8.1% Valuation Models Adjusted Book Value: $2.68 (USD) Multiples: $2.37 (USD) Valuation…
View On WordPress
#Actinium Pharmaceuticals#adjusted book value#AMPE#Ampio Pharmaceuticals#ATNM#comps#Cyclerion Therapeutics#CYCN#DCF#discounted cash flow#fundamental analysis#IBIO#intrinsic value#Matinas BioPharma Hldgs#MTNB#overvalued#Pfenex#PFNX#valuation
0 notes
Last Seen Blogs
lcdyburke-blog
beauty & brains
thequarrey
_
sepprosystem
Sepprosystems
zosiagreene-blog
permets-tu?
thegoldiehanson
Auntie Goldie